The sell cluster is broad but small relative to market cap, and the academic literature discounts the predictive power of cluster sales. Monitor for any subsequent 8-K filings (e.g., earnings, guidance, or material agreements) that could provide context for the insider activity. Without a confirmatory bearish catalyst, this cluster alone does not warrant a directional trade.
Price Chart
Executive Summary
A cluster of open-market share sales by five top executives at MapLight Therapeutics (MPLT) occurred over a two-week window ending July 17, 2026, totaling ~$6.4M. The selling includes the CEO, CAO/Interim CFO, CSO, Chief Discovery Officer, CMO, and General Counsel, but the aggregate value represents only ~0.38% of MPLT's $1.7B market cap — a modest amount. Per academic literature, cluster sales are not reliably informative, and the proportionality is below the threshold for a strong bearish signal.
Key Financial Metrics
Key Facts
- Six senior insiders (CEO, CAO/Interim CFO, CSO, Chief Discovery Officer, CMO, General Counsel) sold shares in a cluster from July 8–17, 2026.
- Total open-market sales: approximately $6.38M (based on trade data from two overlapping windows).
- Sales represent ~0.38% of MPLT's $1.7B market capitalization.
- All transactions were open-market sales (code S); no buys or non-cash grants were reported in the cluster.
- No 10b5-1 plans or other context were disclosed; the timing may reflect a post-blackout window.
Financial Impact
~$6.38M in insider selling, or 0.38% of market cap — modest in size relative to the company's valuation.
Risk Factors
- Further insider selling could accelerate if the pattern continues without explanation.
- The cluster may precede negative news not yet disclosed, increasing the risk of a sell-off.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MPLT-1784541774455 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.66 (+4.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.66 (−28.81%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.66 (−29.72%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.66 (−40.71%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.66 (−40.80%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.66 (+41.17%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.66 (−49.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers